	C 2012 Mar 31	2013 Mar 31	2014 Mar 31	2015 Mar 31	R 2016 Mar 31	2017 Mar 31	C 2018 Mar 31	C 2019 Mar 31	R 2020 Mar 31	2021 Mar 31	2022 Mar 31	2023 Mar 31	2024 Mar 31	R 2025 Mar 31	2026 Mar 31

Period length: Source:	12M AR	12M AR	12M AR	12M AR	12M AR	12M AR	12M AR	12M AR	12M AR	12M AR	12M AR	12M AR	12M AR	12M AR	12M AR
Total Revenue	913	1,106	1,324	1,515	1,593	1,683	1,672	1,814	1,711	1,909	2,196	2,486	2,757	2,844	2,944
Cost of Operating Revenue	554	638	752	848	904	960	942	1,037	992	1,102	1,379	1,528	1,502	1,523	1,669
Gross Profit	359	468	572	667	689	723	730	776	719	807	817	958	1,255	1,321	1,275
Gross Margin	39.3	42.3	43.2	44.0	43.2	42.9	43.7	42.8	42.0	42.3	37.2	38.5	45.5	46.5	43.3
Total Operating Expenses	852	998	1,191	1,202	1,401	1,457	1,446	1,563	1,513	1,650	2,006	2,220	2,327	2,400	2,556
Operating Profit	61	108	133	313	192	225	226	251	198	259	190	266	430	444	389
Operating Margin	6.7	9.7	10.0	20.6	12.0	13.4	13.5	13.8	11.6	13.6	8.7	10.7	15.6	15.6	13.2
Financing Income/(Expense) - Net	-3	-64	-48	-4	-51	-47	-38	-30	-29	-16	-8	-5	20	26	28
Profit before Taxes	58	1	82	125	143	179	241	243	182	235	197	299	479	490	451
Income Taxes	20	-15	1	4	69	-26	62	45	19	44	38	59	110	118	118
Profit after Tax	45	20	81	121	78	208	186	205	170	199	162	240	369	371	333
PAT Margin	4.9	1.8	6.2	8.0	4.9	12.4	11.1	11.3	10.0	10.4	7.4	9.6	13.4	13.1	11.3
EPS - Basic - ex Extraordinary Items	1.38	0.59	2.38	3.35	2.16	5.74	5.12	5.62	4.64	5.43	4.41	6.53	10.06	10.11	9.07
EPS - Diluted - ex Extraordinary Items	1.38	0.59	2.38	3.32	2.13	5.73	5.07	5.62	4.64	5.43	4.41	6.53	10.06	10.10	9.07
EBIT	61	108	133	313	192	225	226	251	198	259	190	266	430	444	389
EBITDA	88	130	157	345	223	256	257	282	251	315	248	316	480	500	450
EBITDA Margin	9.7	11.8	11.9	22.8	14.0	15.2	15.4	15.5	14.7	16.5	11.3	12.7	17.4	17.6	15.3

Balance Sheet

Abridged

Understanding Balance Sheet

Jyothy Labs Ltd. balance sheet covering assets, liabilities, equity and borrowings across annual and quarterly periods.

Consolidated

Standalone

Annual

Interim

	C 2012 Mar 31	R 2013 Mar 31	C 2014 Mar 31	R 2015 Mar 31	R 2016 Mar 31	R 2017 Mar 31	C 2018 Mar 31	C 2019 Mar 31	2020 Mar 31	2021 Mar 31	2022 Mar 31	2023 Mar 31	2024 Mar 31	R 2025 Mar 31	2026 Mar 31

Source:	AR	AR	AR	AR	AR	AR	AR	AR	AR	AR	AR	AR	AR	AR	AR
Total Current Assets	329	349	418	550	456	481	663	622	449	625	724	775	1,139	1,411	1,493
Long-Term Investments	1	1	1	0	0	0	0	0	0	-	-	-	-	-	-
Property Plant & Equipment - Net	324	307	308	300	283	314	313	322	381	366	339	339	347	371	403
Total Non-Current Assets	1,090	1,169	1,236	1,283	1,313	1,372	1,316	1,320	1,387	1,331	1,299	1,287	1,262	612	759
Total Assets	1,419	1,518	1,654	1,833	1,770	1,853	1,979	1,942	1,836	1,956	2,023	2,062	2,401	2,024	2,252
Total Current Liabilities	335	437	232	324	805	742	811	586	545	473	521	406	481	511	556
Long Term Debt	441	427	527	449	7	6	4	2	34	29	24	28	26	37	26
Total Non-Current Liabilities	465	438	686	526	66	28	38	51	92	93	99	104	110	131	107
Total Liabilities	800	875	918	849	871	771	849	637	637	565	620	511	591	641	664
Total Shareholders' Equity	612	639	734	982	901	1,089	1,144	1,327	1,229	1,429	1,444	1,549	1,808	1,383	1,589
Minority Interest	7	5	2	1	-3	-7	-14	-21	-29	-38	-41	2	2	-	-
Total Equity	619	643	736	984	899	1,082	1,130	1,305	1,200	1,391	1,403	1,551	1,810	1,383	1,589
Total Liabilities & Equity	1,419	1,518	1,654	1,833	1,770	1,853	1,979	1,942	1,836	1,956	2,023	2,062	2,401	2,024	2,252

Cash Flow

Abridged

Understanding Cash Flow Statement

Jyothy Labs Ltd. cash flow statement covering operating, investing and financing activities across annual and quarterly periods.

Consolidated

Standalone

Annual

Interim

	C 2012 Mar 31	2013 Mar 31	R 2014 Mar 31	2015 Mar 31	R 2016 Mar 31	2017 Mar 31	C 2018 Mar 31	R 2019 Mar 31	2020 Mar 31	2021 Mar 31	2022 Mar 31	2023 Mar 31	2024 Mar 31	2025 Mar 31	2026 Mar 31

Period length: Source:	12M AR	12M AR	12M AR	12M AR	12M AR	12M AR	12M AR	12M AR	12M AR	12M AR	12M AR	12M AR	12M AR	12M AR	12M AR
Operating CF bef Changes in Working Cap	70	56	82	134	184	81	192	231	205	270	224	275	441	434	413
Working Capital - Increase/(Decrease)	59	-88	-6	23	3	-66	-4	41	-53	105	-26	50	39	-106	12
Net CF from Operating Activities	129	-31	76	157	187	15	189	272	153	375	198	325	479	327	425
Capital Expenditures - Net	23	27	23	16	26	57	-4	38	42	26	21	12	14	58	66
Net CF from Investing Activities	-632	-32	-95	-24	104	-24	-80	26	70	-130	-34	-55	-366	-182	-294
Dividends Paid - Cash - Total	40	20	60	36	145	18	109	18	220	-	147	92	110	129	129
Stock - Issuance/(Retirement) - Net	50	2	263	-	0	0	0	0	-	-	-	-	-	-	-
Debt - LT & ST - Issuance/(Retirement) - Total	474	60	-97	38	-119	47	46	-263	-17	-188	-12	-148	-25	-24	-27
Net Cash Flow from Financing Activities	437	38	95	-4	-293	26	-85	-284	-283	-188	-159	-240	-135	-152	-155
Free Cash Flow to Equity	580	1	-44	179	42	6	239	-29	94	162	164	165	440	246	332
Free Operating CF net dividend	64	-79	-7	104	14	-61	41	214	-110	350	25	198	332	141	229
Free Operating CF	104	-59	52	140	159	-43	150	232	111	350	172	290	442	269	358

Business Segment Analysis

FY End:

Mar 26

Jyothy Labs Ltd. business segment breakdown covering revenue, operating income and assets across key divisions for the selected financial year.

Capex

Unallocated (43.5%)₹ 29.10 CrFabric Care (25.1%)₹ 16.77 CrDishwashing (16.7%)₹ 11.17 CrHousehold Insecticides (8.4%)₹ 5.60 CrPersonal Care (4.4%)₹ 2.97 CrOthers (1.9%)₹ 1.27 Cr

Revenue / Sales

Fabric Care (45.7%)₹ 1,345.88 CrDishwashing (32.6%)₹ 959.31 CrPersonal Care (10.9%)₹ 320.84 CrHousehold Insecticides (6.7%)₹ 196.04 CrOthers (4.2%)₹ 122.22 Cr

Assets

Unallocated (56.0%)₹ 1,261.26 CrFabric Care (18.8%)₹ 423.30 CrDishwashing (13.8%)₹ 310.00 CrHousehold Insecticides (5.0%)₹ 112.23 CrPersonal Care (4.2%)₹ 94.81 CrOthers (2.3%)₹ 50.76 Cr

Regional Segment Analysis

FY End:

Mar 26

Jyothy Labs Ltd. geographic revenue split showing domestic and international market performance across revenue and income for the selected financial year.

Revenue / Sales

india (96.5%)₹ 2,841.29 CrOutside India (3.5%)₹ 103.00 Cr

Historical Segment Analysis

Track how Jyothy Labs Ltd. segment contributions have evolved over multiple financial years to see which divisions are growing, shrinking or gaining strategic importance.

Capex

Sales

Assets

Business

Regional

Business

	2010 Mar 31	2011 Mar 31	2012 Mar 31	2013 Mar 31	2014 Mar 31	2015 Mar 31	2016 Mar 31	2017 Mar 31	2018 Mar 31	2019 Mar 31	2020 Mar 31	2021 Mar 31	2022 Mar 31	2023 Mar 31	2024 Mar 31	2025 Mar 31	2026 Mar 31

Unallocated	2	-	2	2	10	4	9	0	1	2	5	0	8	9	3	21	29
Fabric Care	-	-	-	-	-	-	9	19	10	18	12	10	4	16	19	12	17
Dishwashing	14	8	6	10	11	11	1	19	18	11	20	12	10	6	9	14	11
Household Insecticides	-	-	-	-	-	-	3	8	3	3	1	3	3	2	4	4	6
Personal Care	-	-	-	-	-	-	2	11	4	4	1	1	1	1	1	3	3
Others	0	2	0	0	0	0	0	0	1	0	0	1	0	0	0	4	1
Home Care	8	4	3	0	1	4	-	-	-	-	-	-	-	-	-	-	-
Laundry Services	18	4	13	15	3	12	1	2	2	1	3	1	0	2	-	-	-
Eliminations	-	0	0	0	-	0	-	-	-	-	-	-	-	-	-	-	-

Frequently Asked Questions

What is the revenue of Jyothy Labs Ltd.?

The latest trailing twelve month revenue of Jyothy Labs Ltd. is ₹ 2,944.29 Cr, reflecting a 1-year growth of 3.42% and a 3-year CAGR of 5.80%. Annual and quarterly revenue trends are available in the Income Statement section.

What is the net profit of Jyothy Labs Ltd.?

The latest trailing twelve month net profit (PAT) of Jyothy Labs Ltd. is ₹ 333.19 Cr, with a 3-year earnings CAGR of 11.58%. Detailed profit history across annual and quarterly periods is in the Income Statement section.

What is the EBITDA of Jyothy Labs Ltd.?

The trailing twelve month EBITDA of Jyothy Labs Ltd. is approximately ₹ 388.70 Cr (based on an operating margin of 13.20%). EBITDA reflects core operating profitability before interest, taxes, depreciation and amortisation.

What is the EPS of Jyothy Labs Ltd.?

The trailing twelve month Earnings Per Share (EPS) of Jyothy Labs Ltd. is 9.07. EPS trends across annual and quarterly periods are visible in the Income Statement section.

What is the debt level of Jyothy Labs Ltd.?

The debt-to-equity ratio of Jyothy Labs Ltd. stands at 0.03. The interest coverage ratio is 77.90x, reflecting the company's ability to service debt from operating earnings. The full breakdown of total borrowings is in the Balance Sheet section.

What is the book value per share of Jyothy Labs Ltd.?

The estimated book value per share of Jyothy Labs Ltd. is 44.07 (derived from a P/B ratio of 4.59 and market price of ₹ 202.30), reflecting the net asset value attributable to each share. See the Balance Sheet section for a full breakdown.

What is the cash flow from operations of Jyothy Labs Ltd.?

The trailing twelve month operating cash flow of Jyothy Labs Ltd. is ₹ 424.84 Cr. Annual and quarterly cash flow data is available in the Cash Flow section of the Statements tab.

Does Jyothy Labs Ltd. report consolidated or standalone financials?

Jyothy Labs Ltd. reports consolidated financials. You can toggle between consolidated and standalone views using the switch at the top of each statement section.